Literature DB >> 2553584

Proliferative T-cell response to glycoprotein B of the human herpes viruses: the influence of MHC and sequence of infection on the pattern of cross-reactivity.

W L Chan1, M L Tizard, L Faulkner.   

Abstract

Oligopeptides of the highly conserved herpes virus glycoprotein B (gB) were expressed from DNA fragments of the EBV gB (BALF4) and HSV-2 gB open reading frames as fusion proteins with the lambda CII protein and beta-galactosidase (GZ), respectively, in Escherichia coli. After immunopurification using anti-gB or anti-GZ affinity columns, the fusion proteins were used in vitro to stimulate human peripheral blood lymphocytes (PBL) or murine lymph node cells that have been primed with EBV, HSV-1, HSV-2, VZV or HCMV (all human herpes viruses) to proliferate. Results obtained in BALB/c mice indicate that different herpes viruses induce different levels of T-cell response to each other and to gB, over a range of type-specific and cross-reactive T-cell epitopes. There is a lack of correlation of immunogenicity and antigenicity in the generation of T-cell responses between some of the viruses. Major T-cell epitopes are located at the C terminal half of the gB molecule. The T-cell response to gB in healthy individuals seropositive for various combinations of the five herpes viruses differed markedly from individual to individual, even when they are seropositive to the same set of herpes viruses. However, two individuals with high proliferative T-cell response to VZV and sharing HLA A2, B7, DR2 and DQw1 are also good responders for cross-reactive gB/fragments and for virus antigen of all the five herpes viruses. Therefore the data obtained demonstrated that the MHC and the immune interaction arising from cross-reactive T-cell response evoked by other herpes viruses may determine the pathogenesis of a herpes virus infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553584      PMCID: PMC1385511     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Epstein-Barr virus genome may encode a protein showing significant amino acid and predicted secondary structure homology with glycoprotein B of herpes simplex virus 1.

Authors:  P E Pellett; M D Biggin; B Barrell; B Roizman
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

2.  HLA class II restriction governing cell cooperation between antigen-specific helper T lymphocytes, B lymphocytes and monocytes for in vitro antibody production to influenza virus.

Authors:  A Fischer; G Sterkers; D Charron; A Durandy
Journal:  Eur J Immunol       Date:  1985-06       Impact factor: 5.532

Review 3.  HLA-D region molecules restrict proliferative T cell responses to antigen.

Authors:  E Thorsby; E Berle; H Nousiainen
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

4.  Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals.

Authors:  M D Winther; G Allen; R H Bomford; F Brown
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

5.  Generation of beta-globin by sequence-specific proteolysis of a hybrid protein produced in Escherichia coli.

Authors:  K Nagai; H C Thøgersen
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

6.  Expression in bacteria of gB-glycoprotein-coding sequences of Herpes simplex virus type 2.

Authors:  S Person; S C Warner; D J Bzik; C Debroy; B A Fox
Journal:  Gene       Date:  1985       Impact factor: 3.688

7.  Protective immunization of mice with specific HSV-1 glycoproteins.

Authors:  W L Chan
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

8.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.

Authors:  M Yasukawa; J M Zarling
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

9.  Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.

Authors:  W L Chan; M L Lukig; F Y Liew
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

10.  Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin.

Authors:  C R Parish; F Y Liew
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

View more
  3 in total

1.  Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.

Authors:  L H Nguyen; D M Knipe; R W Finberg
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.

Authors:  Bianca Heemskerk; Louise A Veltrop-Duits; Tamara van Vreeswijk; Monique M ten Dam; Sebastiaan Heidt; Rene E M Toes; Maarten J D van Tol; Marco W Schilham
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.

Authors:  S L Schafer; J Vlach; P M Pitha
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.